Metraipolis › archive › dc_346150d2842e

Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia — Europe PMC PMID:41030857

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41030857
DOI
10.3389/fendo.2025.1654506
License (as archived)
solo-consultazione
Archived
2026-11-09T23:04:37.355Z
SHA-256 of the archived text
5f5e3884c9e3896844e163c5a1f0289ccc719763199732b5820635e04334a400
Stable URL of this page
https://metraipolis.com/documento/dc_346150d2842e

How to cite

Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia — Europe PMC PMID:41030857 — Europe PMC (en), https://europepmc.org/article/MED/41030857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_346150d2842e (Metraipolis archive dc_346150d2842e, sha256 5f5e3884c9e3896844e163c5a1f0289ccc719763199732b5820635e04334a400)
BibTeX
@misc{dc346150d2842e,
  title = {Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia — Europe PMC PMID:41030857},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41030857},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_346150d2842e; sha256 5f5e3884c9e3896844e163c5a1f0289ccc719763199732b5820635e04334a400},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41030857. Agents can read the archived copy with the MCP tool read_document.